The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global CRISPR And CRISPR-Associated Genes Market Research Report 2024
Synopsis
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
The global CRISPR And CRISPR-Associated Genes market was valued at US$ 1384.4 million in 2023 and is anticipated to reach US$ 1770.3 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
This report aims to provide a comprehensive presentation of the global market for CRISPR And CRISPR-Associated Genes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR And CRISPR-Associated Genes.
Report Scope
The CRISPR And CRISPR-Associated Genes market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRISPR And CRISPR-Associated Genes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR And CRISPR-Associated Genes companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Segment by Type
Genome Editing
Genetic Engineering
GRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR And CRISPR-Associated Genes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
The global CRISPR And CRISPR-Associated Genes market was valued at US$ 1384.4 million in 2023 and is anticipated to reach US$ 1770.3 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
This report aims to provide a comprehensive presentation of the global market for CRISPR And CRISPR-Associated Genes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR And CRISPR-Associated Genes.
Report Scope
The CRISPR And CRISPR-Associated Genes market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRISPR And CRISPR-Associated Genes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR And CRISPR-Associated Genes companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Segment by Type
Genome Editing
Genetic Engineering
GRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR And CRISPR-Associated Genes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR And CRISPR-Associated Genes Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Genome Editing
1.2.3 Genetic Engineering
1.2.4 GRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR And CRISPR-Associated Genes Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR And CRISPR-Associated Genes Market Perspective (2019-2030)
2.2 CRISPR And CRISPR-Associated Genes Growth Trends by Region
2.2.1 Global CRISPR And CRISPR-Associated Genes Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CRISPR And CRISPR-Associated Genes Historic Market Size by Region (2019-2024)
2.2.3 CRISPR And CRISPR-Associated Genes Forecasted Market Size by Region (2025-2030)
2.3 CRISPR And CRISPR-Associated Genes Market Dynamics
2.3.1 CRISPR And CRISPR-Associated Genes Industry Trends
2.3.2 CRISPR And CRISPR-Associated Genes Market Drivers
2.3.3 CRISPR And CRISPR-Associated Genes Market Challenges
2.3.4 CRISPR And CRISPR-Associated Genes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR And CRISPR-Associated Genes Players by Revenue
3.1.1 Global Top CRISPR And CRISPR-Associated Genes Players by Revenue (2019-2024)
3.1.2 Global CRISPR And CRISPR-Associated Genes Revenue Market Share by Players (2019-2024)
3.2 Global CRISPR And CRISPR-Associated Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRISPR And CRISPR-Associated Genes Revenue
3.4 Global CRISPR And CRISPR-Associated Genes Market Concentration Ratio
3.4.1 Global CRISPR And CRISPR-Associated Genes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR And CRISPR-Associated Genes Revenue in 2023
3.5 CRISPR And CRISPR-Associated Genes Key Players Head office and Area Served
3.6 Key Players CRISPR And CRISPR-Associated Genes Product Solution and Service
3.7 Date of Enter into CRISPR And CRISPR-Associated Genes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR And CRISPR-Associated Genes Breakdown Data by Type
4.1 Global CRISPR And CRISPR-Associated Genes Historic Market Size by Type (2019-2024)
4.2 Global CRISPR And CRISPR-Associated Genes Forecasted Market Size by Type (2025-2030)
5 CRISPR And CRISPR-Associated Genes Breakdown Data by Application
5.1 Global CRISPR And CRISPR-Associated Genes Historic Market Size by Application (2019-2024)
5.2 Global CRISPR And CRISPR-Associated Genes Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CRISPR And CRISPR-Associated Genes Market Size (2019-2030)
6.2 North America CRISPR And CRISPR-Associated Genes Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CRISPR And CRISPR-Associated Genes Market Size by Country (2019-2024)
6.4 North America CRISPR And CRISPR-Associated Genes Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR And CRISPR-Associated Genes Market Size (2019-2030)
7.2 Europe CRISPR And CRISPR-Associated Genes Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CRISPR And CRISPR-Associated Genes Market Size by Country (2019-2024)
7.4 Europe CRISPR And CRISPR-Associated Genes Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size (2019-2030)
8.2 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size by Region (2019-2024)
8.4 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR And CRISPR-Associated Genes Market Size (2019-2030)
9.2 Latin America CRISPR And CRISPR-Associated Genes Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CRISPR And CRISPR-Associated Genes Market Size by Country (2019-2024)
9.4 Latin America CRISPR And CRISPR-Associated Genes Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size (2019-2030)
10.2 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size by Country (2019-2024)
10.4 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated Genes Introduction
11.1.4 Thermo Fisher Scientific Revenue in CRISPR And CRISPR-Associated Genes Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Editas Medicine
11.2.1 Editas Medicine Company Detail
11.2.2 Editas Medicine Business Overview
11.2.3 Editas Medicine CRISPR And CRISPR-Associated Genes Introduction
11.2.4 Editas Medicine Revenue in CRISPR And CRISPR-Associated Genes Business (2019-2024)
11.2.5 Editas Medicine Recent Development
11.3 Caribou Biosciences
11.3.1 Caribou Biosciences Company Detail
11.3.2 Caribou Biosciences Business Overview
11.3.3 Caribou Biosciences CRISPR And CRISPR-Associated Genes Introduction
11.3.4 Caribou Biosciences Revenue in CRISPR And CRISPR-Associated Genes Business (2019-2024)
11.3.5 Caribou Biosciences Recent Development
11.4 CRISPR therapeutics
11.4.1 CRISPR therapeutics Company Detail
11.4.2 CRISPR therapeutics Business Overview
11.4.3 CRISPR therapeutics CRISPR And CRISPR-Associated Genes Introduction
11.4.4 CRISPR therapeutics Revenue in CRISPR And CRISPR-Associated Genes Business (2019-2024)
11.4.5 CRISPR therapeutics Recent Development
11.5 Intellia therapeutics, Inc.
11.5.1 Intellia therapeutics, Inc. Company Detail
11.5.2 Intellia therapeutics, Inc. Business Overview
11.5.3 Intellia therapeutics, Inc. CRISPR And CRISPR-Associated Genes Introduction
11.5.4 Intellia therapeutics, Inc. Revenue in CRISPR And CRISPR-Associated Genes Business (2019-2024)
11.5.5 Intellia therapeutics, Inc. Recent Development
11.6 Cellectis
11.6.1 Cellectis Company Detail
11.6.2 Cellectis Business Overview
11.6.3 Cellectis CRISPR And CRISPR-Associated Genes Introduction
11.6.4 Cellectis Revenue in CRISPR And CRISPR-Associated Genes Business (2019-2024)
11.6.5 Cellectis Recent Development
11.7 Horizon Discovery Plc
11.7.1 Horizon Discovery Plc Company Detail
11.7.2 Horizon Discovery Plc Business Overview
11.7.3 Horizon Discovery Plc CRISPR And CRISPR-Associated Genes Introduction
11.7.4 Horizon Discovery Plc Revenue in CRISPR And CRISPR-Associated Genes Business (2019-2024)
11.7.5 Horizon Discovery Plc Recent Development
11.8 Sigma Aldrich
11.8.1 Sigma Aldrich Company Detail
11.8.2 Sigma Aldrich Business Overview
11.8.3 Sigma Aldrich CRISPR And CRISPR-Associated Genes Introduction
11.8.4 Sigma Aldrich Revenue in CRISPR And CRISPR-Associated Genes Business (2019-2024)
11.8.5 Sigma Aldrich Recent Development
11.9 Precision Biosciences
11.9.1 Precision Biosciences Company Detail
11.9.2 Precision Biosciences Business Overview
11.9.3 Precision Biosciences CRISPR And CRISPR-Associated Genes Introduction
11.9.4 Precision Biosciences Revenue in CRISPR And CRISPR-Associated Genes Business (2019-2024)
11.9.5 Precision Biosciences Recent Development
11.10 Genscript
11.10.1 Genscript Company Detail
11.10.2 Genscript Business Overview
11.10.3 Genscript CRISPR And CRISPR-Associated Genes Introduction
11.10.4 Genscript Revenue in CRISPR And CRISPR-Associated Genes Business (2019-2024)
11.10.5 Genscript Recent Development
11.11 Sangamo Biosciences Inc.
11.11.1 Sangamo Biosciences Inc. Company Detail
11.11.2 Sangamo Biosciences Inc. Business Overview
11.11.3 Sangamo Biosciences Inc. CRISPR And CRISPR-Associated Genes Introduction
11.11.4 Sangamo Biosciences Inc. Revenue in CRISPR And CRISPR-Associated Genes Business (2019-2024)
11.11.5 Sangamo Biosciences Inc. Recent Development
11.12 Lonza Group Limited
11.12.1 Lonza Group Limited Company Detail
11.12.2 Lonza Group Limited Business Overview
11.12.3 Lonza Group Limited CRISPR And CRISPR-Associated Genes Introduction
11.12.4 Lonza Group Limited Revenue in CRISPR And CRISPR-Associated Genes Business (2019-2024)
11.12.5 Lonza Group Limited Recent Development
11.13 Integrated DNA Technologies
11.13.1 Integrated DNA Technologies Company Detail
11.13.2 Integrated DNA Technologies Business Overview
11.13.3 Integrated DNA Technologies CRISPR And CRISPR-Associated Genes Introduction
11.13.4 Integrated DNA Technologies Revenue in CRISPR And CRISPR-Associated Genes Business (2019-2024)
11.13.5 Integrated DNA Technologies Recent Development
11.14 New England Biolabs
11.14.1 New England Biolabs Company Detail
11.14.2 New England Biolabs Business Overview
11.14.3 New England Biolabs CRISPR And CRISPR-Associated Genes Introduction
11.14.4 New England Biolabs Revenue in CRISPR And CRISPR-Associated Genes Business (2019-2024)
11.14.5 New England Biolabs Recent Development
11.15 Origene Technologies
11.15.1 Origene Technologies Company Detail
11.15.2 Origene Technologies Business Overview
11.15.3 Origene Technologies CRISPR And CRISPR-Associated Genes Introduction
11.15.4 Origene Technologies Revenue in CRISPR And CRISPR-Associated Genes Business (2019-2024)
11.15.5 Origene Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
